|
Other issues |
Clinical PharmacistOpinion
How education should link with career paths
A Sinclair, D Terry
CP 2011;3:312
Editor’s choice
A big shift from where we are now
M Wright
CP 2011;3:312
Update
Xigris withdrawn globally due to poor efficacy
CP 2011;3:315
More data needed for new leukaemia regimen
CP 2011;3:315
Early HIV treatment linked with better outcomes for patients with comorbid tuberculosis
CP 2011;3:315
New specials tariff announced
CP 2011;3:315
Combined oral contraceptives containing newer progestogens associated with higher VTE rates
CP 2011;3:317
Views sought on hospital standards
CP 2011;3:317
Meeting
British Oncology Pharmacy Association conference
Chemotherapy dataset will boost intelligence
M Wright
CP 2011;3:318
Innovative clinical trial design needed to exploit personalised medicine
M Wright
CP 2011;3:318
News feature
Is there a middle ground for outpatient dispensing?
K Towers
CP 2011;3:321
FAQ
Oseltamivir for patients taking methotrexate
CP 2011;3:322
Clinical focus
Thyroid disorders: clinical features and diagnosis
J Lloyd, P Yerbury, V Ruszala
CP 2011;3:323
Thyroid disorders: management
J Lloyd, P Yerbury, V Ruszala
CP 2011;3:330
Lifelong Learning (Thyroid disorders)
CP 2011;3:293
Columnist
Reflections of an independent prescriber
The loose ends are sorted. Job done
C Dixon
CP 2011;3:338
Learning light
Treatments for people with ADHD
M Sie
CP 2011;3:342
Career development
Appraisals and development plans — is mentoring the missing link?
H Middleton
CP 2011;3:345
Viewpoint
Is there a place for therapeutic drug monitoring of olanzapine?
R J Flanagan, P Morgan
CP 2011;3:303
